AU6003596A - The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence - Google Patents

The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence

Info

Publication number
AU6003596A
AU6003596A AU60035/96A AU6003596A AU6003596A AU 6003596 A AU6003596 A AU 6003596A AU 60035/96 A AU60035/96 A AU 60035/96A AU 6003596 A AU6003596 A AU 6003596A AU 6003596 A AU6003596 A AU 6003596A
Authority
AU
Australia
Prior art keywords
human
adrenoceptor
activates
selective agonist
fold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60035/96A
Other languages
English (en)
Inventor
Theresa A Branchek
Douglas A. Craig
Carlos C Forray
Charles Gluchowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synaptic Pharmaceutical Corp
Original Assignee
Synaptic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/459,410 external-priority patent/US5610174A/en
Application filed by Synaptic Pharmaceutical Corp filed Critical Synaptic Pharmaceutical Corp
Publication of AU6003596A publication Critical patent/AU6003596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU60035/96A 1995-06-02 1996-05-30 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence Abandoned AU6003596A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45984695A 1995-06-02 1995-06-02
US08/459,410 US5610174A (en) 1995-06-02 1995-06-02 Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
US459410 1995-06-02
PCT/US1996/007979 WO1996038143A1 (fr) 1995-06-02 1996-05-30 Utilisation d'agents agonistes du recepteur adrenergique alpha-1c-selectif dans le traitement de l'incontinence urinaire
US459846 1999-12-13

Publications (1)

Publication Number Publication Date
AU6003596A true AU6003596A (en) 1996-12-18

Family

ID=27039338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60035/96A Abandoned AU6003596A (en) 1995-06-02 1996-05-30 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence

Country Status (5)

Country Link
EP (1) EP0835107A1 (fr)
JP (1) JPH11507024A (fr)
AU (1) AU6003596A (fr)
CA (1) CA2222573A1 (fr)
WO (1) WO1996038143A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
US20020183357A1 (en) * 2000-02-17 2002-12-05 Brioni Jorge D. Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
JPWO2015152196A1 (ja) * 2014-03-31 2017-04-13 東レ株式会社 イミダゾリン誘導体及びその医薬用途
CN105622434B (zh) * 2015-12-31 2018-03-13 天津英吉诺科技有限公司 1‑(2,5‑二甲氧基苯基)‑2‑氨基乙醇的制备方法

Also Published As

Publication number Publication date
CA2222573A1 (fr) 1996-12-05
WO1996038143A1 (fr) 1996-12-05
EP0835107A1 (fr) 1998-04-15
JPH11507024A (ja) 1999-06-22

Similar Documents

Publication Publication Date Title
US5610174A (en) Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
AU2018282747B2 (en) Compounds for modulating S1P1 activity and methods of using the same
AU680457B2 (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
US5578611A (en) Use of α-1C specific compounds to treat benign prostatic hyperplasia
JP7463318B2 (ja) ６員アザヘテロ環を含有するデルタ－オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法
US5508306A (en) Aromatic amine derivatives
JP2022547079A (ja) てんかんを治療する方法を使用しててんかんを治療する方法
US6583140B2 (en) 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
WO1995007075A9 (fr) Nouveaux derives d'amine aromatique
IL228318A (en) An octahydrothianocoquinoline product
AU6003596A (en) The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
US6218390B1 (en) Morpholinone and morpholine derivatives and uses thereof
US6706716B2 (en) Compounds specific for the human α1d adrenergic receptor and uses thereof
US6602888B2 (en) Use of α1C specific compounds to treat benign prostatic hyperplasia
Craig et al. Use of α1A‐selective adrenoceptor agonists for the treatment of urinary incontinence
US20040106623A1 (en) Compounds specific for the human alpha1d adrenergic receptor and uses thereof
WO2014190942A1 (fr) Composé d'indole, et procédé de préparation, composition pharmaceutique et utilisation de celui-ci